Aesthetic Surgery Journal Open Forum最新文献

{"title":"Do Absorbable Sutures Work for Rectus Diastasis Repair in Abdominoplasty Patients?","authors":"Brandon T Jackson, Simon Moradian, Jonathan T Bricker, Kareem M Termanini, Sarah Ferenz, Jennifer Bai, John Y Kim","doi":"10.1093/asjof/ojae040","DOIUrl":"https://doi.org/10.1093/asjof/ojae040","url":null,"abstract":"\u0000 \u0000 \u0000 The standard treatment for rectus diastasis is rectus sheath plication during abdominoplasty. Lasting correction of diastasis is essential, but there is currently a debate as to whether absorbable or non-absorbable rectus plication achieves a lower rate of recurrence.\u0000 \u0000 \u0000 \u0000 The goal of this study is to assess long-term patient outcomes and recurrence of rectus diastasis after plication with long lasting absorbable sutures.\u0000 \u0000 \u0000 \u0000 A retrospective study of abdominoplasties performed by the senior author between 2018 and 2022 was performed. Only female patients with greater than 6 months of follow-up were included. Plication of the rectus muscles was performed with a combination of interrupted, buried, figure of eight #0 PDS and running #0 Maxon. Outcomes were assessed by physical examination at post-operative visits. A retrospective chart review was used to obtain demographic and perioperative information.\u0000 \u0000 \u0000 \u0000 Seventy-one patients underwent abdominoplasty with an average follow up of 21.1 months. Average age was 43 years and average BMI was 27 kg/m2. Correction of rectus diastasis was performed using absorbable sutures in all patients with no recurrence of diastasis in any patient (0% diastasis recurrence rate). Complications included delayed wound healing (11%), seroma (8.5%), hematoma (2.8%), and deep vein thrombosis/pulmonary embolism (2.8%). No patients needed reoperation.\u0000 \u0000 \u0000 \u0000 Abdominal wall plication using a double-layered, long lasting absorbable suture closure is a safe, reliable, and effective method to address rectus diastasis during abdominoplasty. Our technique achieved no recurrence of diastasis in any patient and a low complication profile.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"56 28","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141103143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expansion of Renuvion Application to Areas Beyond the Submental Region: Review and Experience","authors":"Cassandra R Driscoll, Amelia L Davidson, Matthew N Marturano, Bill G Kortesis, Gaurav Bharti","doi":"10.1093/asjof/ojae041","DOIUrl":"https://doi.org/10.1093/asjof/ojae041","url":null,"abstract":"\u0000 \u0000 \u0000 Minimally invasive and consistent skin redraping following liposuction remains an elusive goal. Application of Renuvion® (Apyx Medical, Clearwater FL, USA), helium induced cold atmospheric plasma provides coagulation, collagen contraction, and subsequent skin tightening making this elusive goal attainable.\u0000 \u0000 \u0000 \u0000 The objective of this study is to evaluate energy settings, and the safety profile of Renuvion® in an effort to achieve optimal cosmesis through the improvement of skin laxity.\u0000 \u0000 \u0000 \u0000 A retrospective review at a single site evaluated cases of Renuvion® between March 2020 and May 2022. Energy settings, use of concomitant VASER® (Solta Medical, Bothwell WA, USA) liposuction frequency, and adverse events were analyzed.\u0000 \u0000 \u0000 \u0000 In total, 180 patients were evaluated, of which 135 (75%) underwent concomitant VASER® liposuction. Renuvion® was used on the abdomen (47.8%), thighs (45.6%), arms (27.2%), submental region (25%), hip rolls (21.2%), and back (19.4%). Amongst the entire cohort, there were a total of 24 (13.3%) complications. Complications consisted of 3 (12.5%) hematomas, 1 (4.2%) burn, 6 (25%) persistent skin laxity with two returned operating room (OR) treatments, 4 (16.7%) seromas, 9 (37.5%) postoperative lymphedema that self-resolved, and 1 (4.2%) self-limited neuralgia. There were no complications that required immediate return to the OR.\u0000 \u0000 \u0000 \u0000 Renuvion® utilization with or without VASER® has a relatively high complication rate – with minor complications as the most common – relatively safe barring proper patient selection that can mitigated with proper patient selection.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141107552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Combined Approach Using IncobotulinumtoxinA and CPM-Hyaluronic Acid Injections for the Periorbital Complex Improvement: A Pilot Study","authors":"Carla Pecora, Bruno Vella Pateo, Gisele Jacobino de Barros Nunes, Abdulay Ezequiel Machado Lanna Queiroz, Bruno Rebelo Lages da Silveira, Jani Van Loghen","doi":"10.1093/asjof/ojae027","DOIUrl":"https://doi.org/10.1093/asjof/ojae027","url":null,"abstract":"\u0000 \u0000 \u0000 Previous reports have objectively demonstrated the efficacy of botulinum toxin for brow elevation. No previous clinical trial has reported a combined approach of botulinum toxin A (BoNT-A) injection with hyaluronic acid (HA) injection in the upper face for the periorbital region beautification focusing on eyebrow reshaping.\u0000 \u0000 \u0000 \u0000 To evaluate the effect of IncobotulinumtoxinA injection using the ONE21 technique combined with HA injection (CPM technology) to redefine brow shape and position.\u0000 \u0000 \u0000 \u0000 A prospective pilot study was designed to evaluate the effect of IncobotulinumtoxinA injection using the ONE21 technique – with a pre-stablished scheme of doses and injection site distribution – combined with HA injection (CPM technology) periosteally into the palpebro-malar groove and subdermally in the anterior temporal region, to redefine brow shape and position. Objective eyebrow measurements were taken by an independent investigator using the Merz Aesthetic Scale (MAS) for brow positioning. Patient satisfaction was also evaluated. Some patients were also assessed using the Vectra System.\u0000 \u0000 \u0000 \u0000 Eleven females, aged 29-55-years, were included in this prospective pilot study. The totality of patients (11/100%) had at least ≥ 1-point improvement in the MAS brow positioning. All patients (100%) reported significant aesthetic improvement of their periorbital region and appearance, being 82% of the patients much improved. Mild side effects were reported as ecchymosis and transient temporal edema were reported.\u0000 \u0000 \u0000 \u0000 The combined technique improved appearance of the orbital area by uplifting the lateral eyebrow and creating an almond-shaped eye effect, which characterizes the trending marketing term Foxy eyes. Further studies including more cases are needed to obtain a statistically significant outcome.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"37 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141109228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and Validation of a Composite Skin Quality Scale","authors":"Michael Gold, Z. P. Lorenc, Lawrence S Bass, David Bank, Jeanine Downie, Gilberto Bellia, A. Giori, Franco Grimolizzi","doi":"10.1093/asjof/ojae038","DOIUrl":"https://doi.org/10.1093/asjof/ojae038","url":null,"abstract":"\u0000 \u0000 \u0000 The increasing demand for skin quality interventions in aesthetic medicine underscores the necessity for objective, evidence-based assessment tools that may be used to evaluate novel interventions or devices.\u0000 \u0000 \u0000 \u0000 To develop and validate a 5-point photo-numeric rating scale for assessing overall skin quality, including radiance, color evenness, and smoothness.\u0000 \u0000 \u0000 \u0000 The IBSA (Institut Biochimique SA) Composite Skin Quality Scale was developed and underwent live validation with 88 real-world patients, chosen to encompass a broad spectrum of skin qualities and Fitzpatrick skin types. Scale validation was performed by board-certified plastic surgeons and dermatologists over 2 rounds, 2 weeks apart. Reliability was assessed via intrarater and interrater agreements, utilizing weighted kappa statistics and intraclass correlation coefficient (ICC). The scale's ability to discern a clinically relevant 1-grade difference was evaluated with 72 photo pairs.\u0000 \u0000 \u0000 \u0000 Combined intrarater reliability results showed weighted kappa values of 0.812 (right side) and 0.815 (left side), and an ICC of 0.903 for both sides, indicating almost perfect agreement. Interrater reliability ranged from substantial to almost perfect, with kappa coefficients between 0.654 and 0.853, and ICCs from 0.657 to 0.855 across all rater pairs in both rounds. The ability to detect a clinically relevant 1-point difference using the scale was established.\u0000 \u0000 \u0000 \u0000 Integrating various key aspects of skin quality, the IBSA Composite Skin Quality Scale is a clinically relevant and highly reliable tool, suitable for skin assessment in clinical studies of new aesthetic technologies and products.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"37 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141109581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Revision Breast Reconstruction With Biologic or Synthetic Mesh: An Analysis of Post-Operative Capsular Contracture Rates","authors":"Jennifer Bai, Sarah Ferenz, Megan Fracol, John Y Kim","doi":"10.1093/asjof/ojae035","DOIUrl":"https://doi.org/10.1093/asjof/ojae035","url":null,"abstract":"\u0000 \u0000 \u0000 Both biologic and synthetic mesh have been found to reduce the risk for capsular contracture, yet there is limited data assessing the use of these scaffold materials in revision breast reconstruction surgery.\u0000 \u0000 \u0000 \u0000 This investigation sought to assess the ability of either biologic or synthetic mesh to prevent capsular contracture in the revision breast reconstruction population.\u0000 \u0000 \u0000 \u0000 A retrospective chart review was conducted of implant-based revision reconstructions performed by the senior author between 2008 and 2023. Patient demographics and outcomes were assessed, including the incidence of Baker grade III or IV capsular contractures. Results were compared between biologic and synthetic mesh groups using univariate and multivariate analysis.\u0000 \u0000 \u0000 \u0000 Ninety-five breasts underwent revision reconstruction with 90 (94.7%) for correction of malposition, four (4.2%) for size change, and one (1.1%) for revision after additional oncologic breast surgery. Of these breasts, 26 (27.4%) used biologic mesh and 69 (72.6%) used synthetic mesh. Capsular contracture occurred in one (3.8%) biologic mesh breast and four (5.8%) synthetic mesh breasts. There was no significant difference in the incidence of capsular contracture between the two groups (p=1.000). None of the recorded demographics were risk factors for capsular contracture, including the use of biologic or synthetic mesh (p=0.801).\u0000 \u0000 \u0000 \u0000 Both biologic and synthetic mesh are successful at preventing capsular contracture in patients undergoing implant-based revision reconstruction. This adds to the growing evidence that both scaffold materials can be used in complex revision breast reconstruction to aid in preventing capsular contracture.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"31 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140966500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complete Vision Recovery After Filler-Induced Blindness Using Hyperbaric Oxygen Therapy: Case Report and Literature Review","authors":"Rebecca Friedman, Allison V Coombs, Shanlee Stevens, R. Lisman, Ernest S Chiu","doi":"10.1093/asjof/ojae036","DOIUrl":"https://doi.org/10.1093/asjof/ojae036","url":null,"abstract":"\u0000 Injecting soft tissue fillers like hyaluronic acid has become an extremely popular method of facial augmentation. Although rare, adverse effects, ranging from cosmetically dissatisfactory to dangerous may occur. The most severe adverse effect of these is vascular occlusion of the central retinal artery, resulting in vision loss. Protocols for the treatment of filler-induced blindness have not been well established, but there is evidence to suggest that hyperbaric oxygen therapy (HBOT) may aid in the therapeutic algorithm of filler-induced blindness. We present a clinical case of filler-induced blindness successfully treated with prompt administration of HBOT.\u0000 A 38-year-old healthy woman presented to the emergency room after immediate pain and complete vision loss following at-home injection of mail-order filler into the left glabella and medial eyebrow. After treatment with hyaluronidase and ocular massage, neither of which relieved her symptoms, she received HBOT within 10 hours of injury, after which her vision improved significantly. After two additional sessions the patient had complete vision recovery.\u0000 This case report contributes to very sparse literature documenting successful treatment of filler-induced blindness using HBOT, advocating for further study and possible incorporation into the treatment algorithm for filler-induced blindness. Improper soft tissue filler administration possesses a potential risk for severe adverse effects. It is crucial that the medical community are aware of treatments that offer the highest chance of visual recovery and sustained benefit for patients.","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":" September","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141127816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Multicentric & Retrospective Clinical Study: Two Years Follow-up Results for Breast Surgery With Perle™ Smooth Opaque Silicone Breast Implants","authors":"Jean-Luc Jauffret","doi":"10.1093/asjof/ojae029","DOIUrl":"https://doi.org/10.1093/asjof/ojae029","url":null,"abstract":"\u0000 \u0000 \u0000 For breast surgery, there are a number of implants available which offer different options such as shape, surface characteristics, gel-fillers and size/profile to meet the diverse needs of the patient population. Each implant option has its own advantages and disadvantages and the individual patient needs should be taken into account when making choices.\u0000 \u0000 \u0000 \u0000 To conduct an assessment of the safety, performance, and satisfaction rates through a two-year follow-up study for the PERLE™ mammary implant.\u0000 \u0000 \u0000 \u0000 Retrospective, observational, multi-center, non-comparative study conducted from March 2023 to June 2023. The collection of data took place in 5 centres across France and Italy. Patients included in the study received the evaluated device between October 2020 and June 2021 for cosmetic and medical indications.\u0000 \u0000 \u0000 \u0000 Of the 97 patients included in the study, only 9 patients reported complications during the two years following the surgery. The overall complication rate was 9.28%. All patients and surgeons were satisfied or very satisfied with the surgery and the implant.\u0000 \u0000 \u0000 \u0000 This patient cohort showed a rate of complication consistent with the range of other smooth implants after 2-years follow up and a high rate of both patient and surgeon satisfaction.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"20 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140660108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unleashing the Power of Biosensors and AI in Dermatology","authors":"D. Haykal","doi":"10.1093/asjof/ojae030","DOIUrl":"https://doi.org/10.1093/asjof/ojae030","url":null,"abstract":"","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"47 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140662181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of a Combination Approach to Improving Muscle Tone and Decreasing Subcutaneous Tissue Thickness Using a Sequential, Dual-Modality, Energy-Based Device","authors":"Kenneth Rothaus, Courtney Brown","doi":"10.1093/asjof/ojae024","DOIUrl":"https://doi.org/10.1093/asjof/ojae024","url":null,"abstract":"\u0000 \u0000 \u0000 The body shaping market has long been at the forefront of the aesthetic industry. With technological advances, patient demand for body sculpting in terms of reduction in subcutaneous tissue and enhancement of muscle has seen continual growth. Several devices have emerged in the space, however few that achieve both SQR (Subcutaneous Tissue Reduction) and VMI (Voluntary Muscle Increase) as measured by thickness, during the same treatment session.\u0000 \u0000 \u0000 \u0000 This article presents the results of a pilot study on a unique approach to subcutaneous tissue reduction and increasing muscle thickness using a dual modality, energy-based device.\u0000 \u0000 \u0000 \u0000 12 compliant subjects (8 female and 4 male with an average age of 40 years were enrolled in this single center, prospective study. All subjects were treated with the dual modality device (850 nm super-luminescent diode matrix and electrical muscle stimulation) with external applicators being placed over the lower abdomen. The subjects received five (5) weekly treatments. Ultrasound measurements, photos, weight and waist measurements were taken at baseline, prior to the start of the 5th treatments and at the two (2) week and two (2) month follow-up visits.\u0000 \u0000 \u0000 \u0000 At the two (2) month follow up visit, the average Subcutaneous Tissue Reduction (SQR) was 34.03% and the Voluntary Muscle Increase (VMI) measured 22.97% in all subjects who completed the study. All subject and physician evaluations rated results as satisfactory or better. There were no complications.\u0000 \u0000 \u0000 \u0000 Preliminary data shows this dual-modality, Electrical Muscle Stimulation/Super Luminescent Diode Matrix (EMS/SDM) system provides both a safe and effective treatment for the reduction of subcutaneous tissue thickness and increase in muscle definition and thickness. Objective and subjective evaluations demonstrated high levels of efficacy and satisfaction in all subjects.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"29 42","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140672211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of Breast Implant Cohesivity on Rippling and Revision Procedures in Two-Stage Prepectoral Breast Reconstruction","authors":"Neil Parikh, Goutam Gadiraju, Matthew Prospero, Yizhuo Shen, Bryce F Starr, Erik Reiche, Colby J. Hyland, Sarah J. Karinja, Justin M. Broyles","doi":"10.1093/asjof/ojae028","DOIUrl":"https://doi.org/10.1093/asjof/ojae028","url":null,"abstract":"\u0000 \u0000 \u0000 Rippling remains one of the most common complications following prepectoral implant-based reconstruction (IBR).\u0000 \u0000 \u0000 \u0000 The purpose of this study was to assess how implant cohesivity, a measure of elasticity and form stability, effects the incidence of rippling in prepectoral IBR.\u0000 \u0000 \u0000 \u0000 We performed a retrospective cohort study of two-stage prepectoral IBR performed between January 2020 and June 2022 at the Brigham and Women’s Hospital and Dana Farber Cancer Institute, comparing outcomes in patients who received Allergan Natrelle® least cohesive, moderately cohesive, and most cohesive silicone gel implants. Outcomes of interest were rippling and re-operation for fat grafting.\u0000 \u0000 \u0000 \u0000 129 patients were identified, of whom 52 had the least cohesive implants, 24 had the moderately cohesive implants, and 53 patients had the most cohesive implants. Mean follow-up time was 463 (± 220) days. Decreased incidence of rippling was seen with moderately cohesive (OR 0.30, p < 0.05) and most cohesive (OR 0.39, p < 0.05) implants. Third stage re-operation for fat grafting was less frequent in patients with the most cohesive implant (OR 0.07, p < 0.05). In subgroup analyses, the patients with the most cohesive implant, who did not receive fat grafting at the time of initial implant placement, did not require re-operation for fat grafting (0%).\u0000 \u0000 \u0000 \u0000 The use of highly cohesive implants in prepectoral IBR is associated with decreased rippling and fewer re-operations for fat grafting.\u0000","PeriodicalId":512050,"journal":{"name":"Aesthetic Surgery Journal Open Forum","volume":"20 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140667761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}